APO Research

APO RESEARCH · REPORT

Transdermal Skin Patches

Selected research

Industry Growth & Trends

Global Transdermal Skin Patches Industry Growth and Trends Forecast to 2032

Market perspective

The global Transdermal Skin Patches market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Transdermal Skin Patches is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Transdermal Skin Patches is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Transdermal Skin Patches is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Transdermal Skin Patches include Hisamitsu Pharmaceutical, Luye Pharma Group, Mundipharma International, Purdue Pharma, Mylan N.V., Novartis AG, Johnson & Johnson and Teva Pharmaceutical Industries, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Transdermal Skin Patches market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Transdermal Skin Patches market size, estimates, and forecasts are presented in terms of sales volume (M Pcs) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Transdermal Skin Patches market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Transdermal Skin Patches.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Transdermal Skin Patches market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Transdermal Skin Patches Market by Company

Hisamitsu Pharmaceutical

Luye Pharma Group

Mundipharma International

Purdue Pharma

Mylan N.V.

Novartis AG

Johnson & Johnson

Teva Pharmaceutical Industries

Transdermal Skin Patches Segment by Type

Drug in Adhesive

Reservoir

Vapor

Matrix

Others

Transdermal Skin Patches Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Transdermal Skin Patches Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transdermal Skin Patches market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Transdermal Skin Patches and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transdermal Skin Patches.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Transdermal Skin Patches manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Transdermal Skin Patches in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Drug in Adhesive Table 2. Major Company of Reservoir Table 3. Major Company of Vapor Table 4. Major Company of Matrix Table 5. Major Company of Others Table 6. Global Transdermal Skin Patches Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Transdermal Skin Patches Sales by Type (2021-2026) & (M Pcs) Table 8. Global Transdermal Skin Patches Sales Market Share in Volume by Type (2021-2026) Table 9. Global Transdermal Skin Patches Sales by Type (2021-2026) & (US$ Million) Table 10. Global Transdermal Skin Patches Sales Market Share in Value by Type (2021-2026) Table 11. Global Transdermal Skin Patches Price by Type (2021-2026) & (US$/Pcs) Table 12. Global Transdermal Skin Patches Sales by Type (2027-2032) & (M Pcs) Table 13. Global Transdermal Skin Patches Sales Market Share in Volume by Type (2027-2032) Table 14. Global Transdermal Skin Patches Sales by Type (2027-2032) & (US$ Million) Table 15. Global Transdermal Skin Patches Sales Market Share in Value by Type (2027-2032) Table 16. Global Transdermal Skin Patches Price by Type (2027-2032) & (US$/Pcs) Table 17. North America Transdermal Skin Patches Sales by Type (2021-2026) & (M Pcs) Table 18. North America Transdermal Skin Patches Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Transdermal Skin Patches Sales by Type (2021-2026) & (M Pcs) Table 20. Europe Transdermal Skin Patches Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Transdermal Skin Patches Sales by Type (2021-2026) & (M Pcs) Table 22. Asia-Pacific Transdermal Skin Patches Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Transdermal Skin Patches Sales by Type (2021-2026) & (M Pcs) Table 24. Latin America Transdermal Skin Patches Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Transdermal Skin Patches Sales by Type (2021-2026) & (M Pcs) Table 26. Middle East and Africa Transdermal Skin Patches Sales by Type (2021-2026) & (US$ Million) Table 27. Transdermal Skin Patches Industry Trends Table 28. Transdermal Skin Patches Industry Drivers Table 29. Transdermal Skin Patches Industry Opportunities and Challenges Table 30. Transdermal Skin Patches Industry Restraints Table 31. Global Transdermal Skin Patches Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Transdermal Skin Patches Revenue Market Share by Company (2021-2026) Table 33. Global Transdermal Skin Patches Sales by Company (2021-2026) & (M Pcs) Table 34. Global Transdermal Skin Patches Sales Share by Company (2021-2026) Table 35. Global Transdermal Skin Patches Market Price by Company (2021-2026) & (US$/Pcs) Table 36. Global Transdermal Skin Patches Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Transdermal Skin Patches Major Company Production Sites and Headquarters Table 38. Global Transdermal Skin Patches Company, Product Type & Application Table 39. Global Transdermal Skin Patches Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Transdermal Skin Patches by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Transdermal Skin Patches Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Transdermal Skin Patches Sales by Region (2021-2026) & (M Pcs) Table 44. Global Transdermal Skin Patches Sales Market Share in Volume by Region (2021-2026) Table 45. Global Transdermal Skin Patches Sales by Region (2021-2026) & (US$ Million) Table 46. Global Transdermal Skin Patches Sales Market Share in Value by Region (2021-2026) Table 47. Global Transdermal Skin Patches Sales (M Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 48. Global Transdermal Skin Patches Sales by Region (2027-2032) & (M Pcs) Table 49. Global Transdermal Skin Patches Sales Market Share in Volume by Region (2027-2032) Table 50. Global Transdermal Skin Patches Sales by Region (2027-2032) & (US$ Million) Table 51. Global Transdermal Skin Patches Sales Market Share in Value by Region (2027-2032) Table 52. Global Transdermal Skin Patches Sales (M Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2027-2032) Table 53. Global Transdermal Skin Patches Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Transdermal Skin Patches Sales by Application (2021-2026) & (M Pcs) Table 55. Global Transdermal Skin Patches Sales Market Share in Volume by Application (2021-2026) Table 56. Global Transdermal Skin Patches Sales by Application (2021-2026) & (US$ Million) Table 57. Global Transdermal Skin Patches Sales Market Share in Value by Application (2021-2026) Table 58. Global Transdermal Skin Patches Price by Application (2021-2026) & (US$/Pcs) Table 59. Global Transdermal Skin Patches Sales by Application (2027-2032) & (M Pcs) Table 60. Global Transdermal Skin Patches Sales Market Share in Volume by Application (2027-2032) Table 61. Global Transdermal Skin Patches Sales by Application (2027-2032) & (US$ Million) Table 62. Global Transdermal Skin Patches Sales Market Share in Value by Application (2027-2032) Table 63. Global Transdermal Skin Patches Price by Application (2027-2032) & (US$/Pcs) Table 64. North America Transdermal Skin Patches Sales by Application (2021-2026) & (M Pcs) Table 65. North America Transdermal Skin Patches Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Transdermal Skin Patches Sales by Application (2021-2026) & (M Pcs) Table 67. Europe Transdermal Skin Patches Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Transdermal Skin Patches Sales by Application (2021-2026) & (M Pcs) Table 69. Asia-Pacific Transdermal Skin Patches Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Transdermal Skin Patches Sales by Application (2021-2026) & (M Pcs) Table 71. Latin America Transdermal Skin Patches Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Transdermal Skin Patches Sales by Application (2021-2026) & (M Pcs) Table 73. Middle East and Africa Transdermal Skin Patches Sales by Application (2021-2026) & (US$ Million) Table 74. Hisamitsu Pharmaceutical Company Information Table 75. Hisamitsu Pharmaceutical Business Overview Table 76. Hisamitsu Pharmaceutical Transdermal Skin Patches Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 77. Hisamitsu Pharmaceutical Transdermal Skin Patches Product Portfolio Table 78. Hisamitsu Pharmaceutical Recent Development Table 79. Luye Pharma Group Company Information Table 80. Luye Pharma Group Business Overview Table 81. Luye Pharma Group Transdermal Skin Patches Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 82. Luye Pharma Group Transdermal Skin Patches Product Portfolio Table 83. Luye Pharma Group Recent Development Table 84. Mundipharma International Company Information Table 85. Mundipharma International Business Overview Table 86. Mundipharma International Transdermal Skin Patches Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 87. Mundipharma International Transdermal Skin Patches Product Portfolio Table 88. Mundipharma International Recent Development Table 89. Purdue Pharma Company Information Table 90. Purdue Pharma Business Overview Table 91. Purdue Pharma Transdermal Skin Patches Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 92. Purdue Pharma Transdermal Skin Patches Product Portfolio Table 93. Purdue Pharma Recent Development Table 94. Mylan N.V. Company Information Table 95. Mylan N.V. Business Overview Table 96. Mylan N.V. Transdermal Skin Patches Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 97. Mylan N.V. Transdermal Skin Patches Product Portfolio Table 98. Mylan N.V. Recent Development Table 99. Novartis AG Company Information Table 100. Novartis AG Business Overview Table 101. Novartis AG Transdermal Skin Patches Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 102. Novartis AG Transdermal Skin Patches Product Portfolio Table 103. Novartis AG Recent Development Table 104. Johnson & Johnson Company Information Table 105. Johnson & Johnson Business Overview Table 106. Johnson & Johnson Transdermal Skin Patches Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 107. Johnson & Johnson Transdermal Skin Patches Product Portfolio Table 108. Johnson & Johnson Recent Development Table 109. Teva Pharmaceutical Industries Company Information Table 110. Teva Pharmaceutical Industries Business Overview Table 111. Teva Pharmaceutical Industries Transdermal Skin Patches Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 112. Teva Pharmaceutical Industries Transdermal Skin Patches Product Portfolio Table 113. Teva Pharmaceutical Industries Recent Development Table 114. North America Transdermal Skin Patches Market Size Growth Rate (CAGR) by Country (M Pcs): 2021 VS 2025 VS 2032 Table 115. North America Transdermal Skin Patches Sales by Country (2021-2026) & (M Pcs) Table 116. North America Transdermal Skin Patches Sales Market Share by Country (2021-2026) Table 117. North America Transdermal Skin Patches Sales Forecast by Country (2027-2032) & (M Pcs) Table 118. North America Transdermal Skin Patches Sales Market Share Forecast by Country (2027-2032) Table 119. North America Transdermal Skin Patches Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 120. North America Transdermal Skin Patches Market Size by Country (2021-2026) & (US$ Million) Table 121. North America Transdermal Skin Patches Market Share by Country (2021-2026) Table 122. North America Transdermal Skin Patches Market Size Forecast by Country (2027-2032) & (US$ Million) Table 123. North America Transdermal Skin Patches Market Share Forecast by Country (2027-2032) Table 124. Europe Transdermal Skin Patches Market Size Growth Rate (CAGR) by Country (M Pcs): 2021 VS 2025 VS 2032 Table 125. Europe Transdermal Skin Patches Sales by Country (2021-2026) & (M Pcs) Table 126. Europe Transdermal Skin Patches Sales Market Share by Country (2021-2026) Table 127. Europe Transdermal Skin Patches Sales Forecast by Country (2027-2032) & (M Pcs) Table 128. Europe Transdermal Skin Patches Sales Market Share Forecast by Country (2027-2032) Table 129. Europe Transdermal Skin Patches Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 130. Europe Transdermal Skin Patches Market Size by Country (2021-2026) & (US$ Million) Table 131. Europe Transdermal Skin Patches Market Share by Country (2021-2026) Table 132. Europe Transdermal Skin Patches Market Size Forecast by Country (2027-2032) & (US$ Million) Table 133. Europe Transdermal Skin Patches Market Share Forecast by Country (2027-2032) Table 134. Asia-Pacific Transdermal Skin Patches Market Size Growth Rate (CAGR) by Country (M Pcs): 2021 VS 2025 VS 2032 Table 135. Asia-Pacific Transdermal Skin Patches Sales by Country (2021-2026) & (M Pcs) Table 136. Asia-Pacific Transdermal Skin Patches Sales Market Share by Country (2021-2026) Table 137. Asia-Pacific Transdermal Skin Patches Sales Forecast by Country (2027-2032) & (M Pcs) Table 138. Asia-Pacific Transdermal Skin Patches Sales Market Share Forecast by Country (2027-2032) Table 139. Asia-Pacific Transdermal Skin Patches Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 140. Asia-Pacific Transdermal Skin Patches Market Size by Country (2021-2026) & (US$ Million) Table 141. Asia-Pacific Transdermal Skin Patches Market Share by Country (2021-2026) Table 142. Asia-Pacific Transdermal Skin Patches Market Size Forecast by Country (2027-2032) & (US$ Million) Table 143. Asia-Pacific Transdermal Skin Patches Market Share Forecast by Country (2027-2032) Table 144. Latin America Transdermal Skin Patches Market Size Growth Rate (CAGR) by Country (M Pcs): 2021 VS 2025 VS 2032 Table 145. Latin America Transdermal Skin Patches Sales by Country (2021-2026) & (M Pcs) Table 146. Latin America Transdermal Skin Patches Sales Market Share by Country (2021-2026) Table 147. Latin America Transdermal Skin Patches Sales Forecast by Country (2027-2032) & (M Pcs) Table 148. Latin America Transdermal Skin Patches Sales Market Share Forecast by Country (2027-2032) Table 149. Latin America Transdermal Skin Patches Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 150. Latin America Transdermal Skin Patches Market Size by Country (2021-2026) & (US$ Million) Table 151. Latin America Transdermal Skin Patches Market Share by Country (2021-2026) Table 152. Latin America Transdermal Skin Patches Market Size Forecast by Country (2027-2032) & (US$ Million) Table 153. Latin America Transdermal Skin Patches Market Share Forecast by Country (2027-2032) Table 154. Middle East and Africa Transdermal Skin Patches Market Size Growth Rate (CAGR) by Country (M Pcs): 2021 VS 2025 VS 2032 Table 155. Middle East and Africa Transdermal Skin Patches Sales by Country (2021-2026) & (M Pcs) Table 156. Middle East and Africa Transdermal Skin Patches Sales Market Share by Country (2021-2026) Table 157. Middle East and Africa Transdermal Skin Patches Sales Forecast by Country (2027-2032) & (M Pcs) Table 158. Middle East and Africa Transdermal Skin Patches Sales Market Share Forecast by Country (2027-2032) Table 159. Middle East and Africa Transdermal Skin Patches Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 160. Middle East and Africa Transdermal Skin Patches Market Size by Country (2021-2026) & (US$ Million) Table 161. Middle East and Africa Transdermal Skin Patches Market Share by Country (2021-2026) Table 162. Middle East and Africa Transdermal Skin Patches Market Size Forecast by Country (2027-2032) & (US$ Million) Table 163. Middle East and Africa Transdermal Skin Patches Market Share Forecast by Country (2027-2032) Table 164. Key Raw Materials Table 165. Raw Materials Key Suppliers Table 166. Transdermal Skin Patches Distributors List Table 167. Transdermal Skin Patches Customers List Table 168. Research Programs/Design for This Report Table 169. Authors List of This Report Table 170. Secondary Sources Table 171. Primary Sources List of Figures Figure 1. Transdermal Skin Patches Image Figure 2. Global Transdermal Skin Patches Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Transdermal Skin Patches Market Size (2021-2032) & (US$ Million) Figure 4. Global Transdermal Skin Patches Sales (2021-2032) & (M Pcs) Figure 5. Drug in Adhesive Image Figure 6. Global Drug in Adhesive Sales YoY Growth (2021-2032) & (M Pcs) Figure 7. Reservoir Image Figure 8. Global Reservoir Sales YoY Growth (2021-2032) & (M Pcs) Figure 9. Vapor Image Figure 10. Global Vapor Sales YoY Growth (2021-2032) & (M Pcs) Figure 11. Matrix Image Figure 12. Global Matrix Sales YoY Growth (2021-2032) & (M Pcs) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (M Pcs) Figure 15. Global Transdermal Skin Patches Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Transdermal Skin Patches Market Share by Type 2025 VS 2032 Figure 17. North America Transdermal Skin Patches Sales Market Share in Volume by Type in 2025 Figure 18. North America Transdermal Skin Patches Sales Market Share in Value by Type in 2025 Figure 19. Europe Transdermal Skin Patches Sales Market Share in Volume by Type in 2025 Figure 20. Europe Transdermal Skin Patches Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Transdermal Skin Patches Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Transdermal Skin Patches Sales Market Share in Value by Type in 2025 Figure 23. Latin America Transdermal Skin Patches Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Transdermal Skin Patches Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Transdermal Skin Patches Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Transdermal Skin Patches Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Transdermal Skin Patches Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Hospital Pharmacies Image Figure 30. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (M Pcs) Figure 31. Online Pharmacies Image Figure 32. Global Online Pharmacies Sales YoY Growth (2021-2032) & (M Pcs) Figure 33. Retail Pharmacies Image Figure 34. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (M Pcs) Figure 35. Global Transdermal Skin Patches Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Transdermal Skin Patches Market Share by Application 2025 VS 2032 Figure 37. North America Transdermal Skin Patches Sales Market Share in Volume by Application in 2025 Figure 38. North America Transdermal Skin Patches Sales Market Share in Value by Application in 2025 Figure 39. Europe Transdermal Skin Patches Sales Market Share in Volume by Application in 2025 Figure 40. Europe Transdermal Skin Patches Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Transdermal Skin Patches Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Transdermal Skin Patches Sales Market Share in Value by Application in 2025 Figure 43. Latin America Transdermal Skin Patches Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Transdermal Skin Patches Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Transdermal Skin Patches Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Transdermal Skin Patches Sales Market Share in Value by Application in 2025 Figure 47. North America Transdermal Skin Patches Sales by Country: 2021 VS 2025 VS 2032 (M Pcs) Figure 48. North America Transdermal Skin Patches Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Transdermal Skin Patches Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Transdermal Skin Patches Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Transdermal Skin Patches Sales by Country: 2021 VS 2025 VS 2032 (M Pcs) Figure 52. Europe Transdermal Skin Patches Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Transdermal Skin Patches Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Transdermal Skin Patches Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Transdermal Skin Patches Sales by Country: 2021 VS 2025 VS 2032 (M Pcs) Figure 56. Asia-Pacific Transdermal Skin Patches Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Transdermal Skin Patches Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Transdermal Skin Patches Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Transdermal Skin Patches Sales by Country: 2021 VS 2025 VS 2032 (M Pcs) Figure 60. Latin America Transdermal Skin Patches Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Transdermal Skin Patches Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Transdermal Skin Patches Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Transdermal Skin Patches Sales by Country: 2021 VS 2025 VS 2032 (M Pcs) Figure 64. Middle East and Africa Transdermal Skin Patches Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Transdermal Skin Patches Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Transdermal Skin Patches Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Transdermal Skin Patches Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Transdermal Skin Patches Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Drug in Adhesive
  • Reservoir
  • Vapor
  • Matrix
  • Others
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Hisamitsu Pharmaceutical
  • Luye Pharma Group
  • Mundipharma International
  • Purdue Pharma
  • Mylan N.V.
  • Novartis AG
  • Johnson & Johnson
  • Teva Pharmaceutical Industries

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Transdermal Skin Patches Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Transdermal Skin Patches Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Transdermal Skin Patches Market by Type
  6. 1.3.1 Drug in Adhesive
  7. 1.3.2 Reservoir
  8. 1.3.3 Vapor
  9. 1.3.4 Matrix
  10. 1.3.5 Others
  11. 1.4 Global Transdermal Skin Patches Market Size by Type
  12. 1.4.1 Global Transdermal Skin Patches Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Transdermal Skin Patches Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Transdermal Skin Patches Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Transdermal Skin Patches Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Transdermal Skin Patches Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Transdermal Skin Patches Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Transdermal Skin Patches Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Transdermal Skin Patches Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Transdermal Skin Patches Industry Trends
  2. 2.2 Transdermal Skin Patches Industry Drivers
  3. 2.3 Transdermal Skin Patches Industry Opportunities and Challenges
  4. 2.4 Transdermal Skin Patches Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Transdermal Skin Patches Revenue (2021-2026)
  2. 3.2 Global Top Players by Transdermal Skin Patches Sales (2021-2026)
  3. 3.3 Global Top Players by Transdermal Skin Patches Price (2021-2026)
  4. 3.4 Global Transdermal Skin Patches Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Transdermal Skin Patches Major Company Production Sites & Headquarters
  6. 3.6 Global Transdermal Skin Patches Company, Product Type & Application
  7. 3.7 Global Transdermal Skin Patches Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Transdermal Skin Patches Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Transdermal Skin Patches Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Transdermal Skin Patches Tier 1, Tier 2, and Tier 3
4 Transdermal Skin Patches Regional Status and Outlook
  1. 4.1 Global Transdermal Skin Patches Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Transdermal Skin Patches Historic Market Size by Region
  3. 4.2.1 Global Transdermal Skin Patches Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Transdermal Skin Patches Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Transdermal Skin Patches Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Transdermal Skin Patches Forecasted Market Size by Region
  7. 4.3.1 Global Transdermal Skin Patches Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Transdermal Skin Patches Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Transdermal Skin Patches Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Transdermal Skin Patches by Application
  1. 5.1 Transdermal Skin Patches Market by Application
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Retail Pharmacies
  5. 5.2 Global Transdermal Skin Patches Market Size by Application
  6. 5.2.1 Global Transdermal Skin Patches Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Transdermal Skin Patches Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Transdermal Skin Patches Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Transdermal Skin Patches Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Transdermal Skin Patches Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Transdermal Skin Patches Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Transdermal Skin Patches Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Transdermal Skin Patches Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Hisamitsu Pharmaceutical
  2. 6.1.1 Hisamitsu Pharmaceutical Company Information
  3. 6.1.2 Hisamitsu Pharmaceutical Business Overview
  4. 6.1.3 Hisamitsu Pharmaceutical Transdermal Skin Patches Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Hisamitsu Pharmaceutical Transdermal Skin Patches Product Portfolio
  6. 6.1.5 Hisamitsu Pharmaceutical Recent Developments
  7. 6.2 Luye Pharma Group
  8. 6.2.1 Luye Pharma Group Company Information
  9. 6.2.2 Luye Pharma Group Business Overview
  10. 6.2.3 Luye Pharma Group Transdermal Skin Patches Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Luye Pharma Group Transdermal Skin Patches Product Portfolio
  12. 6.2.5 Luye Pharma Group Recent Developments
  13. 6.3 Mundipharma International
  14. 6.3.1 Mundipharma International Company Information
  15. 6.3.2 Mundipharma International Business Overview
  16. 6.3.3 Mundipharma International Transdermal Skin Patches Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Mundipharma International Transdermal Skin Patches Product Portfolio
  18. 6.3.5 Mundipharma International Recent Developments
  19. 6.4 Purdue Pharma
  20. 6.4.1 Purdue Pharma Company Information
  21. 6.4.2 Purdue Pharma Business Overview
  22. 6.4.3 Purdue Pharma Transdermal Skin Patches Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Purdue Pharma Transdermal Skin Patches Product Portfolio
  24. 6.4.5 Purdue Pharma Recent Developments
  25. 6.5 Mylan N.V.
  26. 6.5.1 Mylan N.V. Company Information
  27. 6.5.2 Mylan N.V. Business Overview
  28. 6.5.3 Mylan N.V. Transdermal Skin Patches Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Mylan N.V. Transdermal Skin Patches Product Portfolio
  30. 6.5.5 Mylan N.V. Recent Developments
  31. 6.6 Novartis AG
  32. 6.6.1 Novartis AG Company Information
  33. 6.6.2 Novartis AG Business Overview
  34. 6.6.3 Novartis AG Transdermal Skin Patches Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Novartis AG Transdermal Skin Patches Product Portfolio
  36. 6.6.5 Novartis AG Recent Developments
  37. 6.7 Johnson & Johnson
  38. 6.7.1 Johnson & Johnson Company Information
  39. 6.7.2 Johnson & Johnson Business Overview
  40. 6.7.3 Johnson & Johnson Transdermal Skin Patches Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Johnson & Johnson Transdermal Skin Patches Product Portfolio
  42. 6.7.5 Johnson & Johnson Recent Developments
  43. 6.8 Teva Pharmaceutical Industries
  44. 6.8.1 Teva Pharmaceutical Industries Company Information
  45. 6.8.2 Teva Pharmaceutical Industries Business Overview
  46. 6.8.3 Teva Pharmaceutical Industries Transdermal Skin Patches Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Teva Pharmaceutical Industries Transdermal Skin Patches Product Portfolio
  48. 6.8.5 Teva Pharmaceutical Industries Recent Developments
7 North America by Country
  1. 7.1 North America Transdermal Skin Patches Sales by Country
  2. 7.1.1 North America Transdermal Skin Patches Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Transdermal Skin Patches Sales by Country (2021-2026)
  4. 7.1.3 North America Transdermal Skin Patches Sales Forecast by Country (2027-2032)
  5. 7.2 North America Transdermal Skin Patches Market Size by Country
  6. 7.2.1 North America Transdermal Skin Patches Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Transdermal Skin Patches Market Size by Country (2021-2026)
  8. 7.2.3 North America Transdermal Skin Patches Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Transdermal Skin Patches Sales by Country
  2. 8.1.1 Europe Transdermal Skin Patches Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Transdermal Skin Patches Sales by Country (2021-2026)
  4. 8.1.3 Europe Transdermal Skin Patches Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Transdermal Skin Patches Market Size by Country
  6. 8.2.1 Europe Transdermal Skin Patches Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Transdermal Skin Patches Market Size by Country (2021-2026)
  8. 8.2.3 Europe Transdermal Skin Patches Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Transdermal Skin Patches Sales by Country
  2. 9.1.1 Asia-Pacific Transdermal Skin Patches Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Transdermal Skin Patches Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Transdermal Skin Patches Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Transdermal Skin Patches Market Size by Country
  6. 9.2.1 Asia-Pacific Transdermal Skin Patches Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Transdermal Skin Patches Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Transdermal Skin Patches Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Transdermal Skin Patches Sales by Country
  2. 10.1.1 South America Transdermal Skin Patches Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Transdermal Skin Patches Sales by Country (2021-2026)
  4. 10.1.3 South America Transdermal Skin Patches Sales Forecast by Country (2027-2032)
  5. 10.2 South America Transdermal Skin Patches Market Size by Country
  6. 10.2.1 South America Transdermal Skin Patches Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Transdermal Skin Patches Market Size by Country (2021-2026)
  8. 10.2.3 South America Transdermal Skin Patches Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Transdermal Skin Patches Sales by Country
  2. 11.1.1 Middle East and Africa Transdermal Skin Patches Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Transdermal Skin Patches Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Transdermal Skin Patches Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Transdermal Skin Patches Market Size by Country
  6. 11.2.1 Middle East and Africa Transdermal Skin Patches Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Transdermal Skin Patches Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Transdermal Skin Patches Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Transdermal Skin Patches Value Chain Analysis
  2. 12.1.1 Transdermal Skin Patches Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Transdermal Skin Patches Production Mode & Process
  7. 12.2 Transdermal Skin Patches Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Transdermal Skin Patches Distributors
  10. 12.2.3 Transdermal Skin Patches Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research